About Us
Medical Devices and Pharma LLC is a professional provider of expert regulatory consulting services for manufacturers of medical devices and pharmaceutical products regulated by the United States Food and Drug Administration (FDA), Health Canada, the European Union (EU), and globally.
Our website not only provides regulatory information and assistance, but it is also a consumer-oriented resource designed to present timely safety news, helpful information, and analysis for users of medical devices and pharmaceutical products.
Our Mission
The mission of Medical Devices and Pharma is to provide the highest quality personalized professional regulatory services to our clients.
We maintain vigilance and provide timely safety information to consumers of medical device and pharmaceutical products, and provide insight and guidance to companies in FDA-regulated industries regarding their products, processes, innovation, product safety, and enforcement.
Who We Serve
We proudly support:
- Medical Device Manufacturers seeking compliance with QMSR and ISO 13485
- Startups and SMEs navigating FDA regulatory requirements for the first time
- Regulatory and Quality Professionals looking to expand their expertise
- Educational Institutions preparing the next generation of regulatory experts
Regulatory and Quality Information at Your Fingertips
We designed the Medical Devices and Pharma website to present critical industry information in a well-organized and easy-to-navigate format. We stay up-to-date with regulatory agency announcements and activities, so visitors to the site will see current information about medical devices, pharmaceuticals, biologics, combination products, and other regulated medical products.
Contact us
We are available to respond to regulatory questions, strategies, or managed projects. Do you have regulatory questions about your medical device or pharmaceutical product? Let us know – please contact us and we can provide regulatory guidance and advice for upcoming regulatory projects.
Regulatory and Quality Headlines
FDA Cell and Gene Therapy Potency Guidance
Eight Practical Implications for ManufacturersFDA's November 2026 final guidance moves beyond potency testing to emphasize...
Final Guidance on Potency Assurance for Cell and Gene Therapies
New guidance emphasizes a science- and risk-based approach to ensuring product potency throughout development,...
October 2026 FULL Premarket Notification Clearances Report
293 Clearances and Two De Novo GrantsTraditional 510(k) submissions dominate October decisions, while orthopedic, surgical,...
A Heart Valve Designed to Grow with Children
The new pediatric heart valve could reduce the need for repeat surgeries, but FDA requires additional studies to establish...
October 2026 FDA Premarket Notification Clearances
510(k) Clearances – Robotics, AI and Diagnostics Lead the WatchlistOverview FDA issued 295 premarket notification clearance...
FDA Approves Voceryq, First Plasmid DNA Immunotherapy
Voceryq offers adults with recurrent respiratory papillomatosis a new treatment approach that targets the underlying viral...
Class 1 Recall for HemosIL AcuStar HIT Antibody Test
Performance problems could produce false-negative results, potentially delaying diagnosis of a dangerous reaction to...
When Political Priorities and FDA Science Collide
HHS proposes expanding access to six unapproved peptides despite objections from FDA scientists. This raises questions...
FDA Clears AI Software for Automated Kidney Volume Assessment
AIRA uses artificial intelligence to analyze CT images and measure kidney volume, offering clinicians an automated tool for...
FDA Approves SELUTION SLR Drug-Eluting Balloon
SELUTION SLR Drug-Eluting Balloon. Source: MedAlliance LLCNew PMA approval introduces a sirolimus-eluting balloon treatment...



